Cargando…

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease

Mechanisms that control progression from simple steatosis to steato-hepatitis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) are unknown. SPARC, a secreted matricellular protein, is over-expressed in the liver under chronic injury. Contribution of SPARC accumulation to disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzolini, Guillermo, Atorrasagasti, Catalina, Onorato, Agostina, Peixoto, Estanislao, Schlattjan, Martin, Sowa, Jan-Peter, Sydor, Svenja, Gerken, Guido, Canbay, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768809/ https://www.ncbi.nlm.nih.gov/pubmed/29335425 http://dx.doi.org/10.1038/s41598-017-18981-9

Ejemplares similares

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients
por: Onorato, Agostina M., et al.
Publicado: (2023)

SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response
por: Peixoto, Estanislao, et al.
Publicado: (2016)

Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice
por: Atorrasagasti, Catalina, et al.
Publicado: (2013)

Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
por: Mazzolini, Guillermo, et al.
Publicado: (2020)

4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
por: Rodríguez, Marcelo M., et al.
Publicado: (2021)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

Deficiency of the Promyelocytic Leukemia Protein Fosters Hepatitis C-Associated Hepatocarcinogenesis in Mice
por: Herzer, Kerstin, et al.
Publicado: (2012)

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
por: Fiore, Esteban, et al.
Publicado: (2016)

Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis
por: Sydor, Svenja, et al.
Publicado: (2017)

Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis
por: Elfimova, Natalia, et al.
Publicado: (2012)

Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients
por: Buechter, Matthias, et al.
Publicado: (2018)

From bedside to bench and back again—molecular mechanisms in acute liver failure
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
por: Kälsch, Julia, et al.
Publicado: (2011)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells
por: Sydor, Svenja, et al.
Publicado: (2017)

Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure
por: Anastasiou, Olympia, et al.
Publicado: (2015)

Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure
por: Manka, Paul, et al.
Publicado: (2013)

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
por: Tan, Susanne, et al.
Publicado: (2015)

Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage
por: Schreiter, Thomas, et al.
Publicado: (2016)

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
por: Malvicini, Mariana, et al.
Publicado: (2012)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure
por: Manka, Paul, et al.
Publicado: (2014)

Immunotherapy for liver tumors: present status and future prospects
por: Matar, Pablo, et al.
Publicado: (2009)

Prevention of hepatocellular carcinoma and monitoring of high-risk patients
por: Kaya, Eda, et al.
Publicado: (2022)

SPARC's Initiative
por: Alison Buckholtz
Publicado: (2002)

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
por: Malvicini, Mariana, et al.
Publicado: (2012)

Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics
por: Sydor, Svenja, et al.
Publicado: (2022)

Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C
por: Kahraman, Alisan, et al.
Publicado: (2010)

Spleen Stiffness Differentiates Between Acute and Chronic Liver Damage and Predicts Hepatic Decompensation
por: Meister, Phil, et al.
Publicado: (2019)

Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
por: Gottlieb, Aline, et al.
Publicado: (2019)

Evolution of dental tissue mineralization: an analysis of the jawed vertebrate SPARC and SPARC-L families
por: Enault, Sébastien, et al.
Publicado: (2018)

A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver
por: Manka, Paul, et al.
Publicado: (2022)

NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD
por: Demir, Münevver, et al.
Publicado: (2013)

Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations
por: Atorrasagasti, Catalina, et al.
Publicado: (2021)

Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity
por: Larsen, Frederik T., et al.
Publicado: (2022)

SPARC functions as an inhibitor of adipogenesis
por: Nie, Jing, et al.
Publicado: (2009)

SPARC–Dependent Cardiomyopathy in Drosophila
por: Hartley, Paul S., et al.
Publicado: (2016)

Divergent Expression of SPARC, SPARC-L, and SCPP Genes During Jawed Vertebrate Cartilage Mineralization
por: Romero, Adrian, et al.
Publicado: (2021)

Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience
por: Anastasiou, Olympia E, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5nlil1q6n4aihvcuf1f4smit8h